At a glance
ClinicalIndex Comparison RecordN/ACompleted· 82 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Environmental Toxicants and Inflammatory Markers in Prematurity and Diseases of Prematurity
In Brief
An observational study for Premature Birth. Completed, enrolled 82 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if changes in specific gene products in the placenta or cord/infant blood affect a baby's birth weight, increase the risk of premature birth, or increase the risk of developing diseases of prematurity. We would also like to characterize whether placental epigenetic changes or placental markers of environmental exposures are associated with premature birth.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPremature Birth
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedSep 2011
Primary CompletionAug 2015
TodayJul 2026
First PostedSep 22, 2011
Enrollment StartJun 1, 2009
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 14.8 years ago